124 related articles for article (PubMed ID: 35288172)
1. Design and optimization of myricetin encapsulated nanostructured lipid carriers: In-vivo assessment against cognitive impairment in amyloid beta
Halder T; Patel B; Acharya N
Life Sci; 2022 May; 297():120479. PubMed ID: 35288172
[TBL] [Abstract][Full Text] [Related]
2. Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():1631-1658. PubMed ID: 37020692
[TBL] [Abstract][Full Text] [Related]
3. Berberine loaded nanostructured lipid carrier for Alzheimer's disease: Design, statistical optimization and enhanced in vivo performance.
Raju M; Kunde SS; Auti ST; Kulkarni YA; Wairkar S
Life Sci; 2021 Nov; 285():119990. PubMed ID: 34592234
[TBL] [Abstract][Full Text] [Related]
4. Asiatic Acid Fabricated Nanoconstructs to Mitigate Amyloid Beta
Halder T; Patel B; Acharya N
Pharm Res; 2023 Jan; 40(1):197-213. PubMed ID: 36376605
[TBL] [Abstract][Full Text] [Related]
5. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
6. Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer's Disease in Rat Model.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():4193-4227. PubMed ID: 37534058
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer's Disease: Behavioral and Biochemical Evidence.
Sadegh Malvajerd S; Izadi Z; Azadi A; Kurd M; Derakhshankhah H; Sharifzadeh M; Akbari Javar H; Hamidi M
J Alzheimers Dis; 2019; 69(3):671-686. PubMed ID: 31156160
[TBL] [Abstract][Full Text] [Related]
8. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain.
Salunkhe SS; Bhatia NM; Bhatia MS
Drug Deliv; 2016 May; 23(4):1306-16. PubMed ID: 25080227
[TBL] [Abstract][Full Text] [Related]
9. Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus.
Yu Q; Hu X; Ma Y; Xie Y; Lu Y; Qi J; Xiang L; Li F; Wu W
Drug Deliv; 2016 May; 23(4):1469-75. PubMed ID: 27187522
[TBL] [Abstract][Full Text] [Related]
10. Augmented Oral Bioavailability and Prokinetic Activity of Levosulpiride Delivered in Nanostructured Lipid Carriers.
Arif ST; Zaman SU; Khan MA; Tabish TA; Sohail MF; Arshad R; Kim JK; Zeb A
Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365165
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured lipid carriers for the topical delivery of tretinoin.
Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
[TBL] [Abstract][Full Text] [Related]
12. Eudragit S-100 Surface Engineered Nanostructured Lipid Carriers for Colon Targeting of 5-Fluorouracil: Optimization and In Vitro and In Vivo Characterization.
Borderwala K; Rathod S; Yadav S; Vyas B; Shah P
AAPS PharmSciTech; 2021 Aug; 22(6):216. PubMed ID: 34386888
[TBL] [Abstract][Full Text] [Related]
13. Quercetin-Loaded Nanostructured Lipid Carrier In Situ Gel for Brain Targeting Through Intranasal Route: Formulation, In Vivo Pharmacokinetic and Pharmacodynamic Studies.
Sonawane D; Pokharkar V
AAPS PharmSciTech; 2024 Feb; 25(2):30. PubMed ID: 38316672
[TBL] [Abstract][Full Text] [Related]
14. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies.
Singh A; Neupane YR; Mangla B; Kohli K
J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin.
Zhang K; Lv S; Li X; Feng Y; Li X; Liu L; Li S; Li Y
Int J Nanomedicine; 2013; 8():3227-39. PubMed ID: 24009420
[TBL] [Abstract][Full Text] [Related]
16. Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.
Chen Y; Zhou L; Yuan L; Zhang ZH; Liu X; Wu Q
Int J Nanomedicine; 2012; 7():3023-32. PubMed ID: 22787398
[TBL] [Abstract][Full Text] [Related]
17. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
18. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
Wang W; Chen L; Huang X; Shao A
AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
20. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
